ArticleScientific reports2026
Concentration-dependent aerosol size alters regional deposition and inhalation dose translation.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Inhalation toxicity assessment relies heavily on quantifying both atmospheric concentration (AC) and region-specific internal dose (ID) within the respiratory tract, especially when comparing in vivo toxicity tests with in vitro respiratory cellular toxicity tests. However, for particulate substances, the precise relationship between ID and AC often becomes unclear due to variations in aerosol particle size distribution (PSD). This study aimed to investigate how the PSD of aerosols, generated from non-volatile and water-soluble biocides (benzalkonium chloride, didecyldimethylammonium chloride, polyhexamethylene guanidine phosphate, and paraquat), influences the relationship between AC and region-specific ID in the respiratory tract. Aerosols were generated at various concentrations using an ultrasonic humidifier in a 0.125 m³ acrylic chamber, with PSDs (0.01-10 μm) measured using real-time instruments. Regional deposition rates in the rat respiratory tract were subsequently calculated via the multi-path particle dosimetry (MPPD) model to estimate ID. As solution concentration increased, both AC and the mass median aerodynamic diameter (MMAD) also rose. The ID/AC ratio showed saturating increases in the head (H) and tracheobronchial (TB) regions, but a decreasing trend in the pulmonary (P) region, attributed to a reduction in fine particle fraction. A lognormal distribution-based analysis revealed that the TB region was most sensitive to changes in geometric standard deviation (GSD), whereas the H and P regions were primarily affected by MMAD variations. Crucially, a notable mismatch in ID/AC ratios was identified between the measured PSDs and those assumed under lognormal distribution models, underscoring the vital role of aerosol size characteristics in understanding respiratory deposition efficiency and dose metrics. These findings strongly suggest that a quantitative approach, incorporating measured PSDs, is essential for accurately interpreting and comparing inhalation exposure data across different toxicity evaluation systems. This goes beyond evaluations based solely on external concentrations, highlighting the necessity of detailed aerosol characterization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.